Thursday, November 3, 2016
Wednesday, November 2, 2016
Tuesday, November 1, 2016
Next price..?
A series of social media posts from U.S. Sen. Bernie Sanders sent shares of Eli Lilly and Co. briefly tumbling to a seven-month low.
Sanders' Twitter account posted a link to a Washington Post article detailing the decades-long price increase of a Lilly insulin called Humalog. The price of Humalog has risen from $21 a vial to more than $250 during the last 20 years, according to the Post.
The tweets went out to Sanders' 2.7 million Twitter followers. They were not signed by Sanders. Sanders' account posted several more messages that were sharply critical of the Indianapolis drugmaker.
Lilly in a statement defended its pricing of Humalog, noting the product's revenue has been lagging.
Sanders also targeted Lilly competitor Novo Nordisk, a Danish drugmaker whose insulin price has risen at a rate similar to Humalog, according to the Post.
What is next then?
Monday, October 31, 2016
May Drag...
Federal investigators have obtained a warrant to begin searching a large cache of emails belonging to a top aide to Hillary Clinton, as prosecutors and F.B.I. agents scrambled under intense public pressure to assess their significance before Election Day.
That prompted a renewed interest among agents who had investigated Mrs. Clinton for her use of a private email server as secretary of state. That investigation centered on whether Mrs. Clinton or her aides had mishandled classified information.
FBI agents recently confronted Huma with an e-mail she received in 2010 warning her that her Yahoo e-mail account where she’d “routinely” stored State Department messages, including ones containing classified information may have been compromised.
Mr. Comey has faced widespread criticism since his announcement. Hillary attacking the FBI knowing that the results will come after the election takes place.
However the outcome this time is going to be different. Hillary 's gross negligence plus Uma's negligence beyond may drag both down. Just a thought.
Subscribe to:
Posts (Atom)